chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pityriasis rosea
Clinical narrative: Pityriasis rosea, diagnosed 4/7/2021; This is a spontaneous report from a contactable pharmacist, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration on 03Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine and high cholesterol. Concomitant medications included sumatriptan (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and magnesium supplements (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced pityriasis rosea, which was diagnosed 04Jul2021.The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pityriasis rosea and included treatment with topical antihistamine and steroid cream. The clinical outcome of the event pityriasis rosea was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Erythema, Pruritus, Rash papular
Clinical narrative: the skin around my eyes was red and dry, forehead red and dry; the skin around my eyes was red and dry, forehead red and dry; face slightly red with raised red bumps on cheeks; face slightly red with raised red bumps on cheeks; my right arm it was itchy; This is a spontaneous report from a contactable consumer (patient). A 78-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot #: EN6502) via an unspecified route of administration on 22Mar2021 at 13:00 (at the age of 78-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included sinus, breast cancer, high cholesterol, GERD, asthma, ocular rosacea and dermatomyositis (diagnosed after an allergic reaction 10 years ago with yellow dye 5 while on a low dose Aspirin regimen), all from unspecified dates and unspecified if ongoing. The patient had known allergies to penicillin, brimonidine tartrate (LUMIFY), cefaclor (CECLOR), aspirin and yellow dye #5, all from unspecified dates and unspecified if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications (received within 2 weeks of vaccination) included pitavastatin calcium (LIVALO), mometasone furoate (ASMANEX), budesonide (NASOCORT), ascorbic acid/tocopheryl acetate/xantofyl/zeaxanthin/zinc (AREDS), montelukast sodium (SINGULAIR) and azelastine hydrochloride (AZELA), all taken for unspecified indications on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot #: EN6198) via an unspecified route of administration on 01Mar2021 at 13:00 (at the age of 78-years-old) as a single dose in the right arm for COVID-19 immunization and experienced felt like when you get contrast dye with a CT. On 22Mar2021 at 20:00 the patient experienced the skin around my eyes was red and dry, forehead red and dry, face slightly red with raised red bumps on cheeks and my right arm it was itchy. The events were reported as non-serious. The clinical course was reported as follows: On the evening of the second shot, the skin around my eyes was red and dry, forehead red and dry and face slightly red with raised red bumps on cheeks. The patient took Benadryl (also reported that treatment was not received for the events). Under my right arm it was itchy for two days. The clinical outcomes of the events the skin around my eyes was red and dry, forehead red and dry and face slightly red with raised red bumps on cheeks were recovered/resolved on an unspecified date and my right arm it was itchy was recovered/resolved on 24Mar2021. Since the vaccination, the patient had not been tested for COVID-19.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Oral pruritus, Paraesthesia oral
Clinical narrative: Itching and tingling of mouth; Itching and tingling of mouth; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medications. The patient had allergies to (unspecified) medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 13:00, about 1 hour after the vaccination, the patient experienced itching mouth and tingling mouth. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with BENADRYL. The clinical outcomes of the events itching mouth and tingling mouth were resolved on unknown date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash started on stomach, has spread to back and legs.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypothyroidism and cinnamon allergy. The patient received medication (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced rash which started on stomach, had spread to back and legs. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event rash which started on stomach, had spread to back and legs was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash erythematous, Skin warm, Vaccination site urticaria
Clinical narrative: Burning red rash all over body; Burning red rash all over body; Welts on arm where vaccine was administered; Skin hot to the touch; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 05Apr2021 at 11:15 (at the age of 20-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had penicillin allergy and zucchini allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced burning red rash all over body, welts on arm where vaccine was administered and skin was hot to the touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events burning red rash all over body, welts on arm where vaccine was administered and skin hot to the touch were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Pruritus
Clinical narrative: Felt tired; very itchy back; headache; skin felt numb on mid-upper left side of back; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 01Apr2021 at 13:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included mastectomy (on the right breast) on 31Dec2015 and breast tumor benign in the left breast. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) , lisdexamfetamine mesilate (VYVANSE), vitamin b nos (MANUFACTURER UNKNOWN, vitamin d nos (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient reported that she felt tired but fine, she woke up 3am with a very itchy back, upon scratching her skin felt numb on mid-upper left side of back and she had headache for balance of the day. Then perfectly fine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event felt tired, very itchy back, skin felt numb on mid-upper left side of back and headache was resolved on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen axillary lymph node. It started about 6 days after first dose. I should probably say sore not swollen.; Swollen axillary lymph node. It started about 6 days after first dose. I should probably say sore not swollen.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, recently under control. Concomitant medications included nicotine (NICORETTE) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 the patient experienced swollen axillary lymph node. It started about 6 days after first dose. Reported she should probably say sore not swollen. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lymph node pain, lymphadenopathy axillary was not recovered at the time of reporting.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Pain in extremity, Rash
Clinical narrative: Pain on arm; rash on arm; hair loss in clumps; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient did not receive any medication within two weeks of vaccination. The patient did not have any allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 14:00, the patient experienced pain, rash on arm.  Days later hair loss in clumps was noticed as well on an unknown date in Apr2021. It was unknown whether therapeutic measures were taken as a result for the reported adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events pain, rash on arm and hair loss in clumps was not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia, Toothache, Vaccination site pain
Clinical narrative: tooth pain/ache; aches; pain at injection; fever-like chills; exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration in left arm on 02Apr2021 (at the age of 24-year-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: unknown), via an unspecified route of administration on an unknown date at single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced tooth pain/ache, aches, pain at injection, fever-like chills, exhaustion. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events was recovered in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: nose bleeds; This is a spontaneous report from a contactable nurse, the patient.  A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: El3302) via an unspecified route of administration in the arm left on 09Jan2021 at 09:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included spine surgery, post hysterectomy due to endometriosis. The patient had known allergy to cephalosporins. Concomitant medications included duloxetine hydrochloride (CYMBALTA), magnesium (MANUFACTURER UNKNOWN), paracetamol (TYLENOL) , curcuma longa (TURMERIC), esomeprazole magnesium (NEXIUM) and vitamin d nos (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: Ej1685) via an unspecified route of administration in the left arm on 19Dec2020 at 09:00 AM (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021 the patient experienced nose bleeds. it was reported that not sure if the event was related but worth mentioning, she had never had nose bleeds for no apparent reason but have had 3 since her 2nd vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event nose bleeds was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: All over body rash; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727) via an unspecified route of administration in the arm left on 23Mar2021 at 08:00(at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy,  pollen allergy and minor soy allergy. Concomitant medications included vitamin d nos (VITAMIN D) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021 at 01:00, the patient experienced all over body rash. The patient received  zyrtec as the treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event all over body rash was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Drainage, Fatigue, Musculoskeletal stiffness, Nausea
Clinical narrative: Stiff neck; Extremely nauseous; A lot of drainage; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the right arm on 07Apr2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced stiff neck, extremely nauseous, a lot of drainage and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events stiff neck, extremely nauseous, a lot of drainage and extreme fatigue was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Nausea
Clinical narrative: Nausea; Woozy feeling; Diarrhea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8733) via an unspecified route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder from an unspecified date. Concomitant medications included valproate semisodium (DIVALPROEX SODIUM), and quetiapine fumarate (QUETIAPIN) all from an unspecified date for bipolar disorder. The patient previously took hydrocodone; acetaminophen (VICODIN), diclofenac sodium (MANAFACTURER UNKNOWN), doxycycline hyc (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 15:00 the patient experienced nausea, woozy feeling, diarrhea, headache. The patient did not receive any treatment for the events. It was reported that she just began to feel a little better. She took a week to get the side effects gone. the sheet of symptoms said 1to 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, woozy, diarrhea, headache was resolving at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Joint swelling, Nausea
Clinical narrative: Forearms, elbows and hands were painful; Swollen spot on left wrist that was painful to the touch; Swollen spot on left wrist that was painful to the touch; space between the knuckles on both hands appears swollen; nausea; Sick to my stomach; Feverish; Chills; Sunburned; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 28Mar2021 at 13:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included stroke on an unknown date in Mar2020. Concomitant medications included acetylsalicylic acid (ASPIRIN), venlafaxine hydrochloride (EFFEXOR), atorvastatin (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3); all from unknown date for unspecified indication. The patient previously took CECLOR on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The following week of vaccination on 03Apr2021, the patient experienced sunburned. on 04Apr2021 at 10:00, the patient became sick to stomach, feverish and had chills which patient attributed to the sunburn. On 05Apr2021, the patient's forearms, elbows and hands were painful,  swollen spot-on left wrist which was painful to the touch, the space between the knuckles on both hands appeared swollen and had nausea. It was reported that, while experiencing nausea, chills and feverishness after a sunburn before, the patient had not experienced sore muscles and swelling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event nausea was recovered on 07Apr2021 and of the sunburned, sick to stomach, feverish, chills, forearms, elbows and hands were Painful, swollen spot on left wrist that is painful to the touch, space between the knuckles on both hands appears swollen were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia, Sunburn
Clinical narrative: Forearms, elbows and hands were painful; Swollen spot on left wrist that was painful to the touch; Swollen spot on left wrist that was painful to the touch; space between the knuckles on both hands appears swollen; nausea; Sick to my stomach; Feverish; Chills; Sunburned; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 28Mar2021 at 13:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included stroke on an unknown date in Mar2020. Concomitant medications included acetylsalicylic acid (ASPIRIN), venlafaxine hydrochloride (EFFEXOR), atorvastatin (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3); all from unknown date for unspecified indication. The patient previously took CECLOR on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The following week of vaccination on 03Apr2021, the patient experienced sunburned. on 04Apr2021 at 10:00, the patient became sick to stomach, feverish and had chills which patient attributed to the sunburn. On 05Apr2021, the patient's forearms, elbows and hands were painful,  swollen spot-on left wrist which was painful to the touch, the space between the knuckles on both hands appeared swollen and had nausea. It was reported that, while experiencing nausea, chills and feverishness after a sunburn before, the patient had not experienced sore muscles and swelling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event nausea was recovered on 07Apr2021 and of the sunburned, sick to stomach, feverish, chills, forearms, elbows and hands were Painful, swollen spot on left wrist that is painful to the touch, space between the knuckles on both hands appears swollen were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash macular, Rash morbilliform
Clinical narrative: Measles-like rash on right arm (injection arm).; Raised bumps or spots; Itchy; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8737) via an unspecified route of administration in the right arm on 30Mar2021 at 10:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to a number of foods. Concomitant medications included the second dose of varicella-zoster vaccine rge (SHINGRIX) on15Mar2021 for Varicella immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 14:00, the patient experienced a measles-like rash on the right arm (injection arm). 30 itchy, raised bumps or spots. The patient did not receive any treatment for the reported events. Events did not result in doctor or other healthcare professional office/clinic visits and the emergency room/department or urgent care. The clinical outcome of the events measles-like rash on the right arm (injection arm, itchy and raised bumps or spots was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Muscle spasms, Pain in extremity, Pharyngeal swelling, Rash
Clinical narrative: scratchy throat; swollen throat; mild coughing; rash on chest; Had a very sore arm that day and night, almost like a charlie horse; very sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included guillain barre syndrome (2005 - 2006- hospitalized for 3 months), stable aortic aneurysm, allergy to shellfish and allergy to peanuts(anaphylaxis - peanuts and potentially tree nuts). The patient did not receive any other medications within 2 weeks of COVID-19 vaccination. The patient previously took amoxocilian(MANUFACTURER UNKNOWN) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021, that day and night the patient experienced very sore arm, almost like a charlie horse. On 06Apr2021, the arm was still slightly sore, but a lot better. On 07Apr2021 at 04:00, the patient woke up with a scratchy, swollen throat and mild coughing. On 07Apr2021about 16:00 - 17:00, the patient experienced rash on chest (right side only) and very slightly swollen throat. The patient received  treatment for the events scratchy, swollen throat and mild coughing which included Zyrtec and she did not receive treatment for the events sore arm, charlie horse and rash on chest. The clinical outcome of the events very sore arm, rash on chest and charlie horse were recovered on an unknown date in Apr2021, while that of scratchy, swollen throat and mild coughing were recovered on 07Apr2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Scratch
Clinical narrative: scratchy throat; swollen throat; mild coughing; rash on chest; Had a very sore arm that day and night, almost like a charlie horse; very sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included guillain barre syndrome (2005 - 2006- hospitalized for 3 months), stable aortic aneurysm, allergy to shellfish and allergy to peanuts(anaphylaxis - peanuts and potentially tree nuts). The patient did not receive any other medications within 2 weeks of COVID-19 vaccination. The patient previously took amoxocilian(MANUFACTURER UNKNOWN) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021, that day and night the patient experienced very sore arm, almost like a charlie horse. On 06Apr2021, the arm was still slightly sore, but a lot better. On 07Apr2021 at 04:00, the patient woke up with a scratchy, swollen throat and mild coughing. On 07Apr2021about 16:00 - 17:00, the patient experienced rash on chest (right side only) and very slightly swollen throat. The patient received  treatment for the events scratchy, swollen throat and mild coughing which included Zyrtec and she did not receive treatment for the events sore arm, charlie horse and rash on chest. The clinical outcome of the events very sore arm, rash on chest and charlie horse were recovered on an unknown date in Apr2021, while that of scratchy, swollen throat and mild coughing were recovered on 07Apr2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Head discomfort, Hot flush
Clinical narrative: Cloudy head, not painful, but a stuffy sensation; Hot Flashes; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date (at the age of 25-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration on an unknown date (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not provided. On an unknown date, the patient experienced cloudy head, not painful, but a stuffy sensation, hot flashes and tiredness. The clinical outcome of the events cloudy head, not painful, but a stuffy sensation, hot flashes and tiredness were unknown at the time of reporting.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Loss of smell and taste following first dose of the vaccine; Loss of smell and taste following first dose of the vaccine; This is a spontaneous report from a contactable consumer, the parent. An 80-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Mar2021 at 14:00 (at the age of 80-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to food, medications, or other products. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021, the patient experienced loss of smell and taste following first dose of the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events loss of smell and loss of taste was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention
Clinical narrative: Very difficult time concentrating at work; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 17Mar2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 the patient experienced a very difficult time concentrating at work the week after receiving the first dose of the vaccine. The patient did not receive any treatment for the event. The clinical outcome of the event poor concentration was resolving at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise
Clinical narrative: Fatigue; Headache; Unwell; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 11:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within two weeks prior to the vaccination. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 13:15, the patient experienced fatigue, headache and unwell. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fatigue, headache and unwell was recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about the lot number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Arm sore; Shoulder sore; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) taken on an unknown date for an unknown indication. The patient previously received the first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the left arm on 12Mar2021 at 17:00 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, after the second vaccination, patient experienced arm and shoulder sore, and it's worse at night. Patient took tylenol or advil helps to reduce the pain but it's not going away. It had been almost a week since the second vaccination. No other side effects like chills, fever and other issues were not reported by patient. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received the treatment with tylenol or advil for the events. The clinical outcome of the events arm sore and shoulder sore was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Extremely itchy for almost a week. No rash; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in left arm on 29Mar2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic to iodine. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19 since the vaccination. On 31Mar2021, the patient experienced extremely itchy for almost a week, but no rash. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as the result of adverse event. The clinical outcome of the event itchy was not recovered at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Insomnia
Clinical narrative: Felt a little dizzy; Normal injection site/upper arm pain at first; Joint pain; Headache; Fatigue; Lack of sleep; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the right arm on 06Apr2021 at 13:15 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included cromoglicate sodium (NASALCROM), ascorbic acid (VITAMIN C), calcium (MANUFACTUREER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) and multi vitamins (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the right arm on 16Mar2021 at 12:00 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 20:00, the patient experienced normal injection site/upper arm pain at first. On 06Apr2021, the patient experienced joint pain, headache and fatigue and lack of sleep. On 07Apr2021, the patient felt a little dizzy when the patient first woke up due to lack of sleep because of joint pain. No therapeutic measures were taken for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events normal injection site/upper arm pain at first, joint pain, headache, fatigue, lack of sleep and felt a little dizzy were recovered on 07Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Felt a little dizzy; Normal injection site/upper arm pain at first; Joint pain; Headache; Fatigue; Lack of sleep; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the right arm on 06Apr2021 at 13:15 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included cromoglicate sodium (NASALCROM), ascorbic acid (VITAMIN C), calcium (MANUFACTUREER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) and multi vitamins (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the right arm on 16Mar2021 at 12:00 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 20:00, the patient experienced normal injection site/upper arm pain at first. On 06Apr2021, the patient experienced joint pain, headache and fatigue and lack of sleep. On 07Apr2021, the patient felt a little dizzy when the patient first woke up due to lack of sleep because of joint pain. No therapeutic measures were taken for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events normal injection site/upper arm pain at first, joint pain, headache, fatigue, lack of sleep and felt a little dizzy were recovered on 07Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: Headache; Body ache; Tiredness; Congestion; Chill; Mild throat pain; Feeling tired; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and mild cardiomyopathy. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) 20 (units unspecified), diltiazem (MANUFACTURER UNKNOWN) 60 mg and trazodone (MANUFACTURER UNKNOWN) 50 mg; all from unknown date for unknown indications. The patient previously received amoxicillin and codeine on unknown date for an unspecified indication and the experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 07:00, the patient experienced started feeling tired. On 07Apr2021, the patient experienced body ache, tiredness, congestion, chill and mild throat pain. On 08Apr2021, the patient experienced headache. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events feeling tired, body ache, tiredness, congestion, chill, mild throat pain and headache were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.